146 related articles for article (PubMed ID: 38884843)
1. The role of transforming growth factor-β (TGF-β) in the formation of exhausted CD8 + T cells.
Ma R; Sun JH; Wang YY
Clin Exp Med; 2024 Jun; 24(1):128. PubMed ID: 38884843
[TBL] [Abstract][Full Text] [Related]
2. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.
Jiang W; He Y; He W; Wu G; Zhou X; Sheng Q; Zhong W; Lu Y; Ding Y; Lu Q; Ye F; Hua H
Front Immunol; 2020; 11():622509. PubMed ID: 33633741
[TBL] [Abstract][Full Text] [Related]
3. Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8
Zhang Q; Helfand BT; Carneiro BA; Qin W; Yang XJ; Lee C; Zhang W; Giles FJ; Cristofanilli M; Kuzel TM
Eur Urol; 2018 May; 73(5):648-652. PubMed ID: 29275833
[TBL] [Abstract][Full Text] [Related]
4. The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T cells.
Quatromoni JG; Suzuki E; Okusanya O; Judy BF; Bhojnagarwala P; Venegas O; Eruslanov E; Predina JD; Albelda SM; Singhal S
BMC Immunol; 2013 Jul; 14():30. PubMed ID: 23865808
[TBL] [Abstract][Full Text] [Related]
5. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy.
He QF; Xu Y; Li J; Huang ZM; Li XH; Wang X
Brief Funct Genomics; 2019 Mar; 18(2):99-106. PubMed ID: 29554204
[TBL] [Abstract][Full Text] [Related]
7. TGF-β: Many Paths to CD103
Qiu Z; Chu TH; Sheridan BS
Cells; 2021 Apr; 10(5):. PubMed ID: 33922441
[TBL] [Abstract][Full Text] [Related]
8. The tumor microenvironment shapes the molecular characteristics of exhausted CD8
Cheng H; Ma K; Zhang L; Li G
Cancer Lett; 2021 May; 506():55-66. PubMed ID: 33662493
[TBL] [Abstract][Full Text] [Related]
9. Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer.
Zhang L; Zhang B; Li L; Ye Y; Wu Y; Yuan Q; Xu W; Wen X; Guo X; Nian S
J Cancer Res Clin Oncol; 2023 May; 149(5):2243-2258. PubMed ID: 36107246
[TBL] [Abstract][Full Text] [Related]
10. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
11. TGF-β-p-STAT1-LAIR2 axis has a "self-rescue" role for exhausted CD8
Pan B; Wang Z; Yao Y; Ke X; Shen S; Chen W; Zhang X; Qiu J; Wu X; Tang N
Cell Oncol (Dordr); 2023 Dec; 46(6):1625-1644. PubMed ID: 37223874
[TBL] [Abstract][Full Text] [Related]
12. Reinvigorating exhausted CD8
Hossain MA; Liu G; Dai B; Si Y; Yang Q; Wazir J; Birnbaumer L; Yang Y
Med Res Rev; 2021 Jan; 41(1):156-201. PubMed ID: 32844499
[TBL] [Abstract][Full Text] [Related]
13. The Love-Hate Relationship Between TGF-β Signaling and the Immune System During Development and Tumorigenesis.
Chen B; Mu C; Zhang Z; He X; Liu X
Front Immunol; 2022; 13():891268. PubMed ID: 35720407
[TBL] [Abstract][Full Text] [Related]
14. Improving function of cytotoxic T-lymphocytes by transforming growth factor-β inhibitor in oral squamous cell carcinoma.
Kondo Y; Suzuki S; Takahara T; Ono S; Goto M; Miyabe S; Sugita Y; Ogawa T; Ito H; Satou A; Tsuzuki T; Yoshikawa K; Ueda R; Nagao T
Cancer Sci; 2021 Oct; 112(10):4037-4049. PubMed ID: 34309966
[TBL] [Abstract][Full Text] [Related]
15. CD8
Huang Y; Jia A; Wang Y; Liu G
Immunology; 2023 Jan; 168(1):30-48. PubMed ID: 36190809
[TBL] [Abstract][Full Text] [Related]
16. CD8 co-receptor promotes susceptibility of CD8+ T cells to transforming growth factor-β (TGF-β)-mediated suppression.
Zloza A; Jagoda MC; Lyons GE; Graves MC; Kohlhapp FJ; O'Sullivan JA; Lacek AT; Nishimura MI; Guevara-Patiño JA
Cancer Immunol Immunother; 2011 Feb; 60(2):291-7. PubMed ID: 21193909
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C
Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372
[TBL] [Abstract][Full Text] [Related]
18. Developmental Relationships of Four Exhausted CD8
Beltra JC; Manne S; Abdel-Hakeem MS; Kurachi M; Giles JR; Chen Z; Casella V; Ngiow SF; Khan O; Huang YJ; Yan P; Nzingha K; Xu W; Amaravadi RK; Xu X; Karakousis GC; Mitchell TC; Schuchter LM; Huang AC; Wherry EJ
Immunity; 2020 May; 52(5):825-841.e8. PubMed ID: 32396847
[TBL] [Abstract][Full Text] [Related]
19. The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8(+) T cell immunity.
Ahn YH; Hong SO; Kim JH; Noh KH; Song KH; Lee YH; Jeon JH; Kim DW; Seo JH; Kim TW
Clin Exp Immunol; 2015 Jul; 181(1):164-78. PubMed ID: 25753156
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer.
Chatterjee S; Chatterjee A; Jana S; Dey S; Roy H; Das MK; Alam J; Adhikary A; Chowdhury A; Biswas A; Manna D; Bhattacharyya A
Carcinogenesis; 2021 Feb; 42(1):38-47. PubMed ID: 32832992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
